Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC
Clinical trial NCT03075423 · COMPLETED
Trial details
- NCT number
- NCT03075423
- Sponsor
- Goethe University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-01
- Primary completion
- 2023-11-23
- Enrollment
- 316
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.